“Pharmaceutical company Biopure Corp.’s defamation and trade libel case against a National Institutes of Health official for his statements in an article co-authored for the Journal of the American Medical Association raises concerns about the litigation risks of scientific discourse.” (Sheri Qualters, “Suit Against Scientific Journal Raises Litigation Issues”, National Law Journal, Oct. 31; MassHighTech; Pharmalot).
Comments are closed.